Indianapolis Doctor Charged In Illegal Painkiller Distribution
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Indianapolis Doctor Charged In Illegal Painkiller Distribution

Indianapolis Doctor Charged In Illegal Painkiller Distribution

August 19, 2013
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Luis Agostini
Phone Number: 312-353-7875

Dr. Segun Rasaki accused of insurance fraud and writing prescriptions for painkillers without a legitimate purpose

INDIANAPOLIS -  - Marion County Prosecutor Terry Curry announced today that Indianapolis physician Dr. Segun Rasaki has been charged with 24 felonies for allegedly writing prescriptions for painkiller medications without a legitimate purpose, outside the usual course of professional practice or without a license. He also faces a charge of Insurance Fraud for claims filed with Anthem Blue Cross and Blue Shield. Prosecutor Curry was joined by Indiana Attorney General Greg Zoeller and DEA Special Agent Dennis Wichern in the announcement, each representing cooperating agencies involved in the investigation of the case.

Dr. Segun Rasaki is charged with the following:

          • 23 Counts of Dealing in a Controlled Substance, a Class B Felony
          • 1 Count of Dealing in a Schedule IV Controlled Substance, a Class C Felony
          • 1 Count Insurance Fraud, a Class C Felony

"Prescription medications have unfortunately become the drug of choice for many who abuse drugs in our community," Prosecutor Curry stated at a morning press conference. "Let there be no mistake that we will hold accountable any unscrupulous professional who thinks they can profit by facilitating the distribution of such drugs."

As set forth in the probable cause affidavit, the investigation began in 2009 by the Medicaid Fraud Unit of the Office of the Attorney General and the DEA after the DEA began receiving calls from pharmacists about concerns of Dr. Rasaki's prescribing practices.

“This case should sound the alarm that prescription drug abuse is an epidemic in Indiana made worse by individuals such as this defendant who are accused of overprescribing addictive painkillers to patients.  Having taken action to revoke Rasaki’s medical license and having worked with our local and federal colleagues on this complicated investigation, my office is alerting the public of the danger caused by overprescribing of controlled substances,” said Indiana Attorney General Greg Zoeller, whose office recently launched www.BitterPill.IN.gov, a multiagency effort to curb prescription drug addiction.

Nineteen charges announced today relate to eleven patients identified in the course of the investigation to whom Dr. Rasaki prescribed controlled substances, including Hydrocodone, Tussionex, Methadone and Oxycodone. According to a medical specialist, a legitimate medical diagnosis was never established or confirmed for the eleven patients, and the specialist's review concluded that the controlled substances were prescribed without a legitimate medical purpose. A twentieth charge stems from the alleged prescription for Hydrocodone to an undercover DEA agent without a legitimate purpose.

Four additional charges relate to four prescriptions for controlled substances allegedly distributed by Dr. Rasaki in 2012 after his federal and state licenses were suspended. Following an undercover investigation, in December 2011 the DEA presented Dr. Rasaki with an Order to Show Cause and Immediate Suspension of Registration which stated he issued prescriptions to undercover DEA agents based on inadequate physical examination and despite indications of diversion. His Indiana Controlled Substance Registration was revoked automatically at that time.

A charge of Insurance Fraud stems from findings that Dr. Rasaki allegedly filed more than $5,000 worth of fraudulent claims with Anthem Blue Cross and Blue Shield. In a review of 100 randomly selected claims, all were determined to have been falsely billed to Anthem in such a manner to increase the profit made by Dr. Rasaki. The review identified duplicate billings for the same date of services, "ghost" office visits, and upcoding where the medical records did not support the level of services billed.

Dr. Rasaki is being held at the Marion County jail awaiting an initial hearing on Tuesday at 8:45 a.m. in Criminal Court 20.

A charge of a crime is merely an accusation, and the defendant is presumed innocent until and unless proven guilty.

Note:  The charging information and probable cause affidavit for this case are available at:
http://www.scribd.com/doc/161364179/Segun-Rasaki-Probable-Cause-Affidavit-and-Charging-Information

Parents and children are encouraged to educate themselves about the dangers of drugs by visiting DEA’s interactive websites at www.JustThinkTwice.com, www.GetSmartAboutDrugs.com and www.dea.gov.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Shane Catone Special Agent in Charge - Chicago
@DEAChicagoDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster